SCARF syndrome

SCARF syndrome is an extremely rare genetic disorder whose name is an acronym derived from its major clinical features: Skeletal abnormalities, Cutis laxa (loose, sagging skin), Craniostenosis (premature fusion of skull bones), Ambiguous genitalia, psychomotor Retardation, and Facial abnormalities. The condition affects multiple body systems including the skeletal system, skin, central nervous system, craniofacial structures, and genitourinary system. It was first described by Koppe et al. in 1989. Key clinical features include craniosynostosis leading to abnormal skull shape, generalized cutis laxa giving the skin a prematurely aged appearance, skeletal anomalies such as joint hypermobility and bone abnormalities, ambiguous genitalia or other urogenital malformations, intellectual disability and developmental delay, and distinctive facial features including a flat nasal bridge and abnormal ears. Additional findings may include umbilical and inguinal hernias, nipple anomalies, and cardiac defects. SCARF syndrome has been reported in only a very small number of patients worldwide, making it one of the rarest described genetic conditions. Due to the extremely limited number of cases, the molecular genetic basis of the syndrome has not been fully elucidated. There is no specific cure or targeted therapy for SCARF syndrome. Management is supportive and symptomatic, involving a multidisciplinary team that may include geneticists, orthopedic surgeons, neurosurgeons (for craniosynostosis management), dermatologists, urologists, and developmental specialists to address the various manifestations of the condition.

Common questions about SCARF syndrome